Last updated: 11 September 2024 at 4:15pm EST

Richard Scalzo Net Worth




The estimated Net Worth of Richard William Scalzo is at least $10.8 Million dollars as of 11 September 2024. Mr Scalzo owns over 1,468 units of Dyne Therapeutics stock worth over $3,258,631 and over the last 4 years he sold DYN stock worth over $7,565,972.

Mr Scalzo DYN stock SEC Form 4 insiders trading

Mr has made over 20 trades of the Dyne Therapeutics stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 1,468 units of DYN stock worth $46,815 on 11 September 2024.

The largest trade he's ever made was selling 126,074 units of Dyne Therapeutics stock on 6 September 2024 worth over $4,053,279. On average, Mr trades about 11,747 units every 39 days since 2020. As of 11 September 2024 he still owns at least 99,958 units of Dyne Therapeutics stock.

You can see the complete history of Mr Scalzo stock trades at the bottom of the page.





Mr. Richard Scalzo biography

Richard Scalzo is the VP of Accounting & Admin. and Treasurer at Dyne Therapeutics.



How old is Mr Scalzo?

Mr Scalzo is 33, he's been the VP of Accounting & Admin. and Treasurer of Dyne Therapeutics since . There are 25 older and no younger executives at Dyne Therapeutics. The oldest executive at Dyne Therapeutics, Inc. is Yuezhou Ou, 68, who is the Independent Non-Executive Director.

What's Mr Scalzo's mailing address?

Richard's mailing address filed with the SEC is C/O DYNE THERAPEUTICS, INC., 1560 TRAPELO ROAD, WALTHAM, MA, 02451.

Insiders trading at Dyne Therapeutics

Over the last 4 years, insiders at Dyne Therapeutics have traded over $197,573,300 worth of Dyne Therapeutics stock and bought 5,790,447 units worth $92,382,301 . The most active insiders traders include Capital Management, L.P.Kol..., Jason P Rhodes, and Dirk Kersten. On average, Dyne Therapeutics executives and independent directors trade stock every 12 days with the average trade being worth of $3,566,016. The most recent stock trade was executed by Oxana Beskrovnaya on 11 September 2024, trading 2,161 units of DYN stock currently worth $68,914.



What does Dyne Therapeutics do?

Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts..



Complete history of Mr Scalzo stock trades at Dyne Therapeutics

Insider
Trans.
Transaction
Total value
Richard William Scalzo
SVP, Head of Finance, and Admin.
Sale $46,815
11 Sep 2024
Richard William Scalzo
SVP, Head of Finance, and Admin.
Sale $4,053,279
6 Sep 2024
Richard William Scalzo
SVP, Head of Finance, and Admin.
Sale $124,170
19 Aug 2024
Richard William Scalzo
SVP, Head of Finance, and Admin.
Sale $89,792
10 Jun 2024
Richard William Scalzo
SVP, Head of Finance, and Admin.
Sale $73,163
16 May 2024
Richard William Scalzo
SVP, Head of Finance, and Admin.
Sale $2,328,920
8 Mar 2024
Richard William Scalzo
SVP, Head of Finance, and Admin.
Sale $58,757
7 Mar 2024
Richard William Scalzo
SVP, Head of Finance, and Admin.
Option $13,122
29 Feb 2024
Richard William Scalzo
SVP, Head of Finance, and Admin.
Option $13,390
26 Jan 2024
Richard William Scalzo
SVP, Head of Finance, and Admin.
Option $13,390
3 Jan 2024
Richard William Scalzo
SVP, Head of Finance, and Admin.
Sale $28,560
14 Dec 2023
Richard William Scalzo
SVP, Head of Finance, and Admin.
Sale $14,794
11 Dec 2023
Richard William Scalzo
SVP, Head of Finance, and Admin.
Sale $30,662
4 Dec 2023
Richard William Scalzo
SVP, Head of Finance, and Admin.
Sale $12,139
18 Sep 2023
Richard William Scalzo
SVP, Head of Finance, and Admin.
Sale $14,543
12 Sep 2023
Richard William Scalzo
SVP, Head of Finance, and Admin.
Sale $653,167
13 Jun 2023
Richard William Scalzo
SVP, Head of Finance, and Admin.
Sale $17,476
14 Mar 2023
Richard William Scalzo
SVP, Head of Finance, and Admin.
Sale $3,391
9 Dec 2022
Richard William Scalzo
SVP, Head of Finance, and Admin.
Sale $2,689
11 Mar 2022
Richard William Scalzo
SVP, Head of Finance, and Admin.
Sale $13,658
20 Sep 2021


Dyne Therapeutics executives and stock owners

Dyne Therapeutics executives and other stock owners filed with the SEC include: